Suppr超能文献

用于诊断继发性肾上腺皮质功能减退的促肾上腺皮质激素刺激试验:利弊并存。

ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow.

作者信息

Birtolo Maria Francesca, Antonini Simone, Saladino Andrea, Zampetti Benedetta, Lavezzi Elisabetta, Chiodini Iacopo, Mazziotti Gherardo, Lania Andrea G A, Cozzi Renato

机构信息

Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.

Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.

出版信息

Biomedicines. 2023 Mar 15;11(3):904. doi: 10.3390/biomedicines11030904.

Abstract

Secondary Adrenal Insufficiency (SAI) is a condition characterized by inappropriately low ACTH secretion due to a disease or injury to the hypothalamus or the pituitary. The evaluation when suspected is often challenging for the non-specific symptoms, the rarity of the disease, and the pitfalls associated with laboratory tests. A prompt and correct diagnosis of SAI is essential because although an adequate hormonal replacement therapy could be lifesaving, inappropriate life-long therapy with steroids can be harmful. The gold standard test for assessing the hypothalamus-pituitary-adrenal axis (HPA) is the insulin tolerance test (ITT), but due to safety issues is not widely used. Conversely, the ACTH stimulation test is a safer and well-tolerated tool for SAI diagnosis. However, data about its diagnostic accuracy show great variability due to both technical and interpretative aspects, such as dose, route of administration, the timing of the test, and assay used for cortisol measurements. Consequently, the clinical background of the patient and the pretest probability of HPA axis impairment become of paramount importance. We aimed to summarize the recent literature evidence in the conduction and interpretation of the ACTH stimulation test for the diagnosis of SAI to provide updated insights on its correct use in clinical practice.

摘要

继发性肾上腺皮质功能减退(SAI)是一种由于下丘脑或垂体疾病或损伤导致促肾上腺皮质激素(ACTH)分泌不足的病症。当怀疑患有SAI时,由于其非特异性症状、疾病的罕见性以及与实验室检查相关的陷阱,评估往往具有挑战性。SAI的及时正确诊断至关重要,因为尽管适当的激素替代疗法可能挽救生命,但不适当的长期类固醇治疗可能有害。评估下丘脑 - 垂体 - 肾上腺轴(HPA)的金标准测试是胰岛素耐量试验(ITT),但由于安全问题未被广泛使用。相反,ACTH刺激试验是一种用于SAI诊断的更安全且耐受性良好的工具。然而,由于技术和解释方面的原因,如其剂量、给药途径、测试时间以及用于皮质醇测量的检测方法等,关于其诊断准确性的数据显示出很大的变异性。因此,患者的临床背景和HPA轴受损的预测试概率变得至关重要。我们旨在总结近期关于ACTH刺激试验在SAI诊断中的实施和解释的文献证据,以便为其在临床实践中的正确使用提供最新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da74/10045406/34a02f92e0d0/biomedicines-11-00904-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验